Olivier Elemento Selected Research

Adrenergic Uptake Inhibitors

1/2020

A machine learning and network framework to discover new indications for small molecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Elemento Research Topics

Disease

156	Neoplasms (Cancer) 05/2024 - 03/2009
30	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 04/2012
19	Lymphoma (Lymphomas) 01/2023 - 01/2013
18	Breast Neoplasms (Breast Cancer) 04/2024 - 07/2015
16	Neoplasm Metastasis (Metastasis) 11/2023 - 12/2014
10	COVID-19 01/2023 - 01/2020
9	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2015
9	Disease Progression 03/2023 - 04/2013
9	Inflammation (Inflammations) 01/2023 - 01/2018
9	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 05/2013
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 12/2010
8	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 01/2017
7	Adenocarcinoma 03/2022 - 03/2016
6	Carcinoma (Carcinomatosis) 03/2024 - 12/2016
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 12/2018
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 09/2014
6	Obesity 01/2023 - 08/2015
6	Melanoma (Melanoma, Malignant) 01/2022 - 01/2017
5	Triple Negative Breast Neoplasms 11/2020 - 01/2017
4	Infections 05/2022 - 01/2021
4	Multiple Myeloma 09/2021 - 09/2014
4	Carcinogenesis 01/2021 - 08/2015
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023 - 09/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 11/2016
3	Glioma (Gliomas) 01/2023 - 01/2019
3	Primitive Neuroectodermal Tumors (PNET) 12/2022 - 01/2019
3	Hypoxia (Hypoxemia) 09/2021 - 10/2014
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2021 - 01/2017
3	Genomic Instability 01/2021 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2015
3	Bites and Stings (Sting) 01/2021 - 01/2018
3	Leukemia 01/2018 - 11/2012
2	Atherosclerosis 03/2024 - 08/2023
2	Brain Neoplasms (Brain Tumor) 02/2024 - 12/2023
2	Pancreatitis 11/2023 - 01/2021
2	Retinoblastoma (Glioblastoma, Retinal) 03/2023 - 01/2019
2	Pneumonia (Pneumonitis) 02/2023 - 01/2021
2	Body Weight (Weight, Body) 01/2023 - 01/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 01/2019

Drug/Important Bio-Agent (IBA)

37	RNA (Ribonucleic Acid)IBA 03/2024 - 04/2013
25	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2010
25	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 10/2010
17	Biomarkers (Surrogate Marker)IBA 10/2023 - 11/2012
11	Transcription Factors (Transcription Factor)IBA 01/2023 - 06/2012
10	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 02/2013
8	ChromatinIBA 11/2023 - 06/2012
7	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2009
6	EnzymesIBA 02/2024 - 04/2015
6	Messenger RNA (mRNA)IBA 12/2023 - 12/2014
6	Histones (Histone)IBA 01/2022 - 09/2014
6	LigandsIBA 01/2020 - 01/2015
5	Cell-Free Nucleic AcidsIBA 01/2024 - 01/2020
5	Drug CombinationsIBA 01/2024 - 01/2017
5	VaccinesIBA 10/2022 - 01/2016
5	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2018
5	Hormones (Hormone)IBA 01/2020 - 01/2017
4	Phosphotransferases (Kinase)IBA 05/2024 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2016
4	CytokinesIBA 10/2023 - 01/2018
4	Estrogens (Estrogen)FDA Link 01/2023 - 01/2017
4	AntigensIBA 01/2023 - 03/2016
4	LipidsIBA 01/2023 - 01/2018
4	Histone MethyltransferasesIBA 01/2022 - 05/2013
4	NucleotidesIBA 11/2021 - 01/2020
4	Protein Isoforms (Isoforms)IBA 03/2021 - 01/2019
4	hydrogen sulfite (bisulfite)IBA 01/2021 - 04/2013
4	Phenobarbital (Luminal)FDA Link 01/2021 - 12/2018
4	CytosineIBA 01/2018 - 11/2012
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2024 - 10/2022
3	durvalumabIBA 01/2024 - 01/2021
3	Insulin (Novolin)FDA Link 12/2023 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2021
3	Histone Deacetylase InhibitorsIBA 12/2022 - 06/2017
3	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 08/2014
3	Circulating Tumor DNAIBA 11/2021 - 01/2020
3	InterferonsIBA 09/2021 - 01/2018
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2021 - 10/2016
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021 - 01/2018
3	PlatinumIBA 01/2020 - 07/2015
3	Small Interfering RNA (siRNA)IBA 01/2020 - 12/2010
3	TIC10 compoundIBA 01/2019 - 11/2016
2	AntibodiesIBA 03/2024 - 10/2017
2	Methionine (L-Methionine)FDA Link 02/2024 - 01/2022
2	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 06/2023
2	Alkylating AgentsIBA 01/2024 - 06/2023
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 06/2023
2	talazoparibIBA 01/2024 - 06/2023
2	IntegrinsIBA 11/2023 - 12/2016
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 09/2014
2	Dinoprostone (PGE2)FDA Link 01/2023 - 01/2019
2	HydrogelsIBA 01/2023 - 01/2022
2	ParaffinIBA 01/2023 - 08/2021
2	Cyclic AMP (AMP, Cyclic)IBA 01/2023 - 01/2022

Therapy/Procedure

63	Therapeutics 04/2024 - 11/2012
19	Precision Medicine 04/2024 - 05/2015
14	Castration 01/2024 - 04/2013
12	Immunotherapy 02/2024 - 01/2016
11	Drug Therapy (Chemotherapy) 01/2023 - 01/2016
3	Radiotherapy 02/2024 - 01/2019
2	Aftercare (After-Treatment) 12/2023 - 01/2022